The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
NOX1, 2, 4, 5: counting out oxidative stress
Open accessAbstract
For decades, oxidative stress has been discussed as a key mechanism of endothelial dysfunction and cardiovascular disease. However, attempts to validate and exploit this hypothesis clinically by supplementing antioxidants have failed. Nevertheless, this does not disprove the oxidative stress hypothesis. As a certain degree of reactive oxygen species (ROS) formation appears to be physiological and beneficial. To reduce oxidative stress therapeutically, two alternative approaches are being developed. One is the repair of key signalling components that are compromised by oxidative stress. These include uncoupled endothelial nitric oxide (NO) synthase and oxidized/heme‐free NO receptor soluble guanylate cyclase. A second approach is to identify and effectively inhibit the relevant source(s) of ROS in a given disease condition. A highly likely target in this context is the family of NADPH oxidases. Animal models, including NOX knockout mice and new pharmacological inhibitors of NADPH oxidases have opened up a new era of oxidative stress research and have paved the way for new cardiovascular therapies. LINKED ARTICLES This article is part of a themed issue on Vascular Endothelium in Health and Disease. To view the other articles in this issue visit http://dx.doi.org/10.1111/bph.2011.164.issue‐3
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Instead, apocynin directly scavenges ROS due to its antioxidant capacities [340,395,396,397,398].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [340]
In the citing paper
“Apocynin was long considered as specific Nox2 inhibitor. However, several studies have shown that this is indeed not the case.”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [340]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989
Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., Franklin, B., Kris-Etherton, P., Harris, W. S., Howard, B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176158 · Cited by 2,705
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,651
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577
Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
Gryglewski, R. J., Palmer, R. M. J., & Moncada, S. (1986) · Nature · doi:10.1038/320454a0 · Cited by 2,400
Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2007) · JAMA · doi:10.1001/jama.297.8.842 · Cited by 2,275
Primary Prevention of Coronary Heart Disease in Women through Diet and Lifestyle
Stampfer, M. J., Hu, F. B., Manson, J. E., Rimm, E. B., & Willett, W. C. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007063430103 · Cited by 1,794
Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200314172 · Cited by 1,660
Landmesser, U., Dikalov, S., Price, S. R., McCann, L. A., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci14172 · Cited by 1,652
Antioxidants prevent health-promoting effects of physical exercise in humans
Ristow, M., Zarse, K., Oberbach, A., Klöting, N., Birringer, M., Kiehntopf, M., Stumvoll, M., Kahn, C. R., & Blüher, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903485106 · Cited by 1,582
A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish
Niethammer, P., Grabher, C., Look, A. T., & Mitchison, T. J. (2009) · Nature · doi:10.1038/nature08119 · Cited by 1,541
Treasure, C. B., Klein, J., Weintraub, W. S., Talley, J., Stillabower, M., Kosinski, A. S., Zhang, J., Boccuzzi, S., Cedarholm, J. C., & Alexander, R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502233320801 · Cited by 1,335
Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor
Rubanyi, G. M., & Vanhoutte, P. M. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.250.5.h822 · Cited by 1,193
Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181
Tadalafil Therapy for Pulmonary Arterial Hypertension
Galiè, N., Brundage, B. H., Ghofrani, H. A., Oudiz, R. J., Simonneau, G., Safdar, Z., Shapiro, S., White, R. J., Chan, M., Beardsworth, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.839274 · Cited by 1,096
Vivekananthan, D. P., Penn, M. S., Sapp, S. K., Hsu, A., & Topol, E. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13637-9 · Cited by 1,083
&NA; (1996) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-199605000-00005 · Cited by 1,071
Lipid peroxidation: Physiological levels and dual biological effects
Niki, E. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.05.032 · Cited by 1,032
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S., Puigserver, P., & Brugge, J. S. (2009) · Nature · doi:10.1038/nature08268 · Cited by 1,031
Vascular NAD(P)H oxidases: specific features, expression, and regulation
Lassegue, B. P., & Clempus, R. E. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00758.2002 · Cited by 1,026
Simvastatin, an HMG–Coenzyme A Reductase Inhibitor, Improves Endothelial Function Within 1 Month
O’Driscoll, G., Green, D., & Taylor, R. R. (1997) · Circulation · doi:10.1161/01.cir.95.5.1126 · Cited by 947
Erectile Dysfunction and Subsequent Cardiovascular Disease
Thompson, I. M. (2005) · JAMA · doi:10.1001/jama.294.23.2996 · Cited by 877
Homologs of gp91 phox : cloning and tissue expression of Nox3, Nox4, and Nox5
Cheng, G., Cao, Z., Xu, X., Meir, E. G. V., & Lambeth, J. D. (2001) · Gene · doi:10.1016/s0378-1119(01)00449-8 · Cited by 820
Ristow, M., & Zarse, K. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.03.014 · Cited by 789
NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart
Kuroda, J., Ago, T., Matsushima, S., Zhai, P., Schneider, M. D., & Sadoshima, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002178107 · Cited by 772
Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene
Riemersma, R. A., Wood, D. A., Oliver, M. F., Elton, R. A., Macintyre, C. C. A., & GEY, K. F. (1991) · The Lancet · doi:10.1016/0140-6736(91)93327-6 · Cited by 771
Evgenov, O. V., Pacher, P., Schmidt, P. M., Haskó, G., Schmidt, H. H. H. W., & Stasch, J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2038 · Cited by 758
Self-citationTherapeutic Targeting of Mitochondrial Superoxide in Hypertension
Dikalova, A., Bikineyeva, A. T., Budzyn, K., Nazarewicz, R. R., McCann, L. A., Lewis, W., Harrison, D. G., & Dikalov, S. (2010) · Circulation Research · doi:10.1161/circresaha.109.214601 · Cited by 745
Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an Antioxidant
Heumüller, S., Wind, S., Barbosa-Sicard, E., Schmidt, H. H. H. W., Busse, R., Schröder, K., & Brandes, R. P. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.100214 · Cited by 735
Self-citationOxidative Stress and Cardiovascular Injury
Griendling, K. K., & FitzGerald, G. A. (2003) · Circulation · doi:10.1161/01.cir.0000093661.90582.c4 · Cited by 727
Doughan, A. K., Harrison, D. G., & Dikalov, S. I. (2008) · Circulation Research · doi:10.1161/circresaha.107.162800 · Cited by 710
The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases
Cai, H., Griendling, K. K., & Harrison, D. G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00233-5 · Cited by 687
Zang, M., Xu, S., Maitland, K. A., Zuccollo, A., Hou, X., Jiang, B., Wierzbicki, M., Verbeuren, T. J., & Cohen, R. A. (2006) · Diabetes · doi:10.2337/db05-1188 · Cited by 672
NADPH Oxidases in Cardiovascular Health and Disease
Cave, A. C., Brewer, A. C., Narayanapanicker, A., Ray, R., Grieve, D. J., Walker, S., & Shah, A. M. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.691 · Cited by 630
A Ca2+-activated NADPH Oxidase in Testis, Spleen, and Lymph Nodes
Bánfi, B., Molnár, G., Maturana, A., Steger, K., Hegedûs, B., Demaurex, N., & Krause, K.-H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103034200 · Cited by 622
Rey, F. E., Cifuentes-Pagano, E., Kiarash, A., Quinn, M. T., & Pagano, P. J. (2001) · Circulation Research · doi:10.1161/hh1701.096037 · Cited by 613
Görlach, A., Brandes, R. P., Nguyen, K., Amidi, M., Dehghani, F., & Busse, R. (2000) · Circulation Research · doi:10.1161/01.res.87.1.26 · Cited by 598 · cited 2×
“Nevertheless, it can be said with some certainty that NOX2 is not only present in leukocytes, but also in endothelial cells (Gorlach et al., 2000; Bedard and Krause, 2007), fibroblasts (Chamseddine and Miller, 2003) and cardiac myocytes (Nabeebaccus et al.”
NADPH Oxidases: Functions and Pathologies in the Vasculature
Lassègue, B., & Griendling, K. K. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.181610 · Cited by 592
Cellular Antioxidant Effects of Atorvastatin In Vitro and In Vivo
Waßmann, S., Laufs, U., Müller, K., Konkol, C., Ahlbory, K., Bäumer, A. T., Linz, W., Böhm, M., & Nickenig, G. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0202.104081 · Cited by 590
Touyz, R. M., Chen, X., Tabet, F., Yao, G., He, G., Quinn, M. T., Pagano, P. J., & Schiffrin, E. L. (2002) · Circulation Research · doi:10.1161/01.res.0000020404.01971.2f · Cited by 590
O’Donnell, V. B., Tew, D. G., Jones, O. T. G., & ENGLAND, P. J. (1993) · Biochemical Journal · doi:10.1042/bj2900041 · Cited by 588
Free radicals in cerebral ischemia.
Flamm, E. S., Demopoulos, H. B., Seligman, M. L., Poser, R. G., & Ransohoff, J. (1978) · Stroke · doi:10.1161/01.str.9.5.445 · Cited by 577
Healthy Living Is the Best Revenge
Ford, E. S., Bergmann, M. M., Kröger, J., Schienkiewitz, A., Weikert, C., & Boeing, H. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.237 · Cited by 577
Zhao, H., Joseph, J., Fales, H. M., Sokoloski, E. A., Levine, R. L., Vasquez-Vivar, J., & Kalyanaraman, B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501719102 · Cited by 576
Khaw, K., Bingham, S. A., Welch, A. A., Luben, R., Wareham, N. J., Oakes, S., & Day, N. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04128-3 · Cited by 576
Measurement of Reactive Oxygen Species in Cardiovascular Studies
Dikalov, S., Griendling, K. K., & Harrison, D. G. (2007) · Hypertension · doi:10.1161/01.hyp.0000258594.87211.6b · Cited by 532
Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant
Bowry, V. W., Ingold, K. U., & Stocker, R. (1992) · Biochemical Journal · doi:10.1042/bj2880341 · Cited by 511
Primary Prevention of Stroke by Healthy Lifestyle
Chiuve, S. E., Rexrode, K. M., Spiegelman, D. L., Logroscino, G., Manson, J. E., & Rimm, E. B. (2008) · Circulation · doi:10.1161/circulationaha.108.781062 · Cited by 508
Ago, T., Kuroda, J., Pain, J., Fu, C., Li, H., & Sadoshima, J. (2010) · Circulation Research · doi:10.1161/circresaha.109.213116 · Cited by 506
Subcellular localization of Nox4 and regulation in diabetes
Block, K. L., Gorin, Y. C., & Abboud, H. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906805106 · Cited by 484
Nox1 Is Involved in Angiotensin II–Mediated Hypertension: A Study in Nox1-Deficient Mice
Matsuno, K., Yamada, H., Iwata, K., Jin, D., Katsuyama, M., Matsuki, M., Takai, S., Yamanishi, K., Miyazaki, M., Matsubara, H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.573709 · Cited by 470
Stasch, J., Schmidt, P. M., Nedvetsky, P. I., Nedvetskaya, T. Y., Kumar, A. H. S., Meurer, S., Deile, M., Taye, A., Knorr, A., Lapp, H., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28371 · Cited by 461
Self-citationThe Antioxidants and Pro-Antioxidants Network: An Overview
Vertuani, S., Angusti, A., & Manfredini, S. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384655 · Cited by 449
Kleinschnitz, C., Grund, H., Wingler, K., Armitage, M. E., Jones, E., Mittal, M., Barit, D., Schwarz, T., Geis, C., Kraft, P., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000479 · Cited by 447
Self-citationMethods for detection and measurement of hydrogen peroxide inside and outside of cells
Rhee, S. G., Chang, T.-S., Jeong, W., & Kang, D. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0082-3 · Cited by 446
Dikalova, A., Clempus, R., Lassègue, B., Cheng, G., McCoy, J., Dikalov, S., Martin, A. S., Lyle, A., Weber, D. S., Weiss, D., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.538934 · Cited by 438
Self-citationRajasekaran, N. S., Connell, P., Christians, E. S., Yan, L.-J., Taylor, R. P., Orosz, A., Zhang, X. Q., Stevenson, T. J., Peshock, R. M., Leopold, J. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.06.044 · Cited by 437
Lipid peroxidation cannot be used as a universal criterion of oxidative stress
Dotan, Y. (2003) · Progress in Lipid Research · doi:10.1016/j.plipres.2003.10.001 · Cited by 434
Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension
Schulz, E., Jansen, T., Wenzel, P., Daiber, A., & Münzel, T. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1989 · Cited by 430
Reactive oxygen species as mediators of angiotensin II signaling
Griendling, K. K., & Ushio‐Fukai, M. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00136-1 · Cited by 417
Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking
Lykkesfeldt, J. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.01.028 · Cited by 416
Sedeek, M., Callera, G., Montezano, A., Gutsol, A., Heitz, F., Szyndralewiez, C., Page, P., Kennedy, C. R. J., Burns, K. D., Touyz, R. M., et al. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00028.2010 · Cited by 396
Sorescu, G. P., Song, H. W., Tressel, S. L., Hwang, J., Dikalov, S., Smith, D. A., Boyd, N. L., Platt, M. O., Lassegue, B. P., Griendling, K. K., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000145728.22878.45 · Cited by 383
Mozaffarian, D., Kamineni, A., Carnethon, M., Djoussé, L., Mukamal, K. J., & Siscovick, D. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.21 · Cited by 358
Endothelial Function in Hypertension
McIntyre, M., Bohr, D. F., & Dominiczak, A. F. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.539 · Cited by 355
Reactive oxygen species in hypertension*1An update
Lassegue, B. P. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.02.004 · Cited by 351
Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase
Walder, C. E., Green, S. P., Darbonne, W. C., Mathias, J., Rae, J., Dinauer, M. C., Curnutte, J. T., & Thomas, G. R. (1997) · Stroke · doi:10.1161/01.str.28.11.2252 · Cited by 349
Decreased blood pressure in NOX1‐deficient mice
Gavazzi, G., Banfi, B., Deffert, C., Fiette, L., Schappi, M., Herrmann, F., & Krause, K.-H. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.12.049 · Cited by 321
Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people
Gale, C., Martyn, C., Winter, P., & Cooper, C. (1995) · British medical journal · doi:10.1136/bmj.310.6994.1563 · Cited by 316
Inhibition of NADPH Oxidase is Neuroprotective after Ischemia—Reperfusion
Chen, H., Song, Y. S., & Chan, P. H. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.47 · Cited by 291
Detection of Superoxide in Vascular Tissue
Münzel, T. F., Afanasʹev, I. B., Kleschyov, A. L., & Harrison, D. G. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000034022.11764.ec · Cited by 281
Guzik, T. J., Chen, W., Gongora, M. C., Guzik, B., Lob, H. E., Mangalat, D., Hoch, N., Dikalov, S., Rudzinski, P., Kapelak, B., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.063 · Cited by 281
Glorioso, N., Troffa, C., Filigheddu, F., Dettori, F., Soro, A., Parpaglia, P. P., Collatina, S., & Pahor, M. (1999) · Hypertension · doi:10.1161/01.hyp.34.6.1281 · Cited by 278
NADPH oxidases in cardiovascular disease
Brandes, R. P., Weißmann, N., & Schröder, K. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.04.030 · Cited by 273
Wingler, K., Wünsch, S., Kreutz, R. H., Rothermund, L., Paul, M., & Schmidt, H. H. H. W. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00727-4 · Cited by 273
Self-citationStephens, J. W., Khanolkar, M., & Bain, S. C. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.06.006 · Cited by 262
Fink, B., Laude, K. M., McCann, L. A., Doughan, A. K., Harrison, D. G., & Dikalov, S. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00028.2004 · Cited by 259
TENFREYHAUS, H., HUNTGEBURTH, M., WINGLER, K., SCHNITKER, J., BAUMER, A., VANTLER, M., BEKHITE, M., WARTENBERG, M., SAUER, H., & ROSENKRANZ, S. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.01.022 · Cited by 259
Self-citationTsunekawa, T., Hayashi, T., Kano, H., Sumi, D., Matsui‐Hirai, H., Thakur, N. K., Egashira, K., & Iguchi, A. (2001) · Circulation · doi:10.1161/hc2901.094094 · Cited by 256
NOX5 variants are functionally active in endothelial cells
BelAiba, R. S., Djordjevic, T., Petry, A., Diemer, K., Bonello, S., Banfi, B., Hess, J., Pogrebniak, A., Bickel, C., & Görlach, A. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.10.054 · Cited by 255
Nyyssonen, K., Parviainen, M. T., Salonen, R., Tuomilehto, J. O., & Salonen, J. T. (1997) · BMJ · doi:10.1136/bmj.314.7081.634 · Cited by 254
gp91phox-Containing NADPH Oxidase Mediates Endothelial Dysfunction in Renovascular Hypertension
Jung, O., Schreiber, J. G., Geiger, H., Pedrazzini, T., Busse, R., & Brandes, R. P. (2004) · Circulation · doi:10.1161/01.cir.0000124223.00113.a4 · Cited by 254
Cardounel, A. J., Cui, H., Samouilov, A., Johnson, W., Kearns, P. N., Tsai, A.-L., Berka, V., & Zweier, J. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603606200 · Cited by 249
Selemidis, S., Sobey, C. G., Wingler, K., Schmidt, H. H. H. W., & Drummond, G. R. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.005 · Cited by 249
Self-citationSmall-Molecule NOX Inhibitors: ROS-Generating NADPH Oxidases as Therapeutic Targets
Jaquet, V., Scapozza, L., Clark, R. A., Krause, K. H., & Lambeth, J. D. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2585 · Cited by 245
Comparative pharmacology of chemically distinct nadph oxidase inhibitors
Wind, S., Beuerlein, K., Eucker, T., Müller, H., Scheurer, P., Armitage, M., Ho, H., Schmidt, H., & Wingler, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00920.x · Cited by 241
Self-citationNADPH oxidase 4 is an oncoprotein localized to mitochondria
Graham, K., Kulawiec, M., Owens, K. M., Li, X., Desouki, M. M., Chandra, D., & Singh, K. K. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.3.12207 · Cited by 240
Asymmetric dimethylarginine (ADMA): A novel risk marker in cardiovascular medicine and beyond
Böger, R. H. (2006) · Annals of Medicine · doi:10.1080/07853890500472151 · Cited by 238
Novel NAD(P)H oxidases in the cardiovascular system: Table 1
Griendling, K. K. (2004) · Heart · doi:10.1136/hrt.2003.029397 · Cited by 215
Carotenoids, vitamins C and E, and mortality in an elderly population.
Sahyoun, N. R., Jacques, P. F., & Russell, R. M. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008957 · Cited by 212
NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries
Miller, A. A., Drummond, G. R., Schmidt, H. H. H. W., & Sobey, C. G. (2005) · Circulation Research · doi:10.1161/01.res.0000189301.10217.87 · Cited by 211 · cited 5×
“Likewise, vitamin E supplements can no longer be considered safe for the general population (Dotan et al., 2009; Miller et al., 2005b; Miller and Guallar, 2009).”
InfluentialSelf-citationNovel Mechanism of Activation of NADPH Oxidase 5
Jagnandan, D., Church, J. E., Banfi, B., Stuehr, D. J., Marrero, M. B., & Fulton, D. J. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608966200 · Cited by 210
Classical Inhibitors of NOX NAD(P)H Oxidases Are Not Specific
Aldieri, E., Riganti, C., Polimeni, M., Gazzano, E., Lussiana, C., Campia, I., & Ghigo, D. (2008) · Current Drug Metabolism · doi:10.2174/138920008786049285 · Cited by 201
Majander, A. S., Finel, M., & Wikström, M. K. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31926-9 · Cited by 200
BiP/Kar2p serves as a molecular chaperone during carboxypeptidase Y folding in yeast.
Simons, J. F., Ferro‐Novick, S., Rose, M. D., & Helenius, A. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.130.1.41 · Cited by 199
Diatchuk, V., Lotan, O., Koshkin, V., Wikstroem, P., & Pick, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13292 · Cited by 195
Auch–Schwelk, W., Katušić, Z. S., & Vanhoutte, P. M. (1989) · Hypertension · doi:10.1161/01.hyp.13.6.859 · Cited by 194
Gianni, D., Taulet, N., Zhang, H., DerMardirossian, C., Kister, J., Martinez, L., Roush, W. R., Brown, S. J., Bokoch, G. M., & Rosen, H. (2010) · ACS Chemical Biology · doi:10.1021/cb100219n · Cited by 192
Using Isoprostanes as Biomarkers of Oxidative Stress: Some Rarely Considered Issues
Halliwell, B. B., & Lee, J. C. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2934 · Cited by 191
Mittendorf, J., Weigand, S., Alonso‐Alija, C., Bischoff, E., Feurer, A., Gerisch, M., Kern, A., Knorr, A., Lang, D. H., Muenter, K., et al. (2009) · ChemMedChem · doi:10.1002/cmdc.200900014 · Cited by 189
Vitamin C status and mortality in US adults
Loria, C. M., Klag, M. J., Caulfield, L. E., & Whelton, P. K. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.1.139 · Cited by 188
Gotoh, N., & Niki, E. (1992) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(92)90054-x · Cited by 188
Thomson, L., Trujillo, M., Telleri, R., & Radi, R. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1321 · Cited by 186
Shi, J. N., Ross, C. R., Leto, T. L., & Blecha, F. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.6014 · Cited by 185
Measurement of NAD(P)H oxidase-derived superoxide with the luminol analogue L-012
Daiber, A., August, M., Baldus, S. E., Wendt, M., Oelze, M. W., Sydow, K., Kleschyov, A. L., & Münzel, T. F. (2003) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.10.012 · Cited by 184
Wind, S., Beuerlein, K., Armitage, M. E., Taye, A., Kumar, A. H. S., Janowitz, D., Neff, C., Shah, A. M., Wingler, K., & Schmidt, H. H. H. W. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.149187 · Cited by 181
Self-citationMeasurement of total antioxidant capacity
Young, I. S. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.5.339 · Cited by 180
Dikalova, A. E., Góngora, M. C., Harrison, D. G., Lambeth, J. D., Dikalov, S., & Griendling, K. K. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00242.2010 · Cited by 179
Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cells
Vejražka, M., MICEK, R., & Štípek, S. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.12.008 · Cited by 173
Galle, J., Zabel, U., Hübner, U., Hatzelmann, A., Wagner, B., Wanner, C., & Schmidt, H. H. H. W. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702495 · Cited by 173
Self-citationNox5 mediates PDGF-induced proliferation in human aortic smooth muscle cells
Jay, D. B., Papaharalambus, C. A., Seidel-Rogol, B., Dikalova, A. E., Lassègue, B., & Griendling, K. K. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.04.024 · Cited by 166
Vecchione, C., & Brandes, R. P. (2002) · Circulation Research · doi:10.1161/01.res.0000028004.76218.b8 · Cited by 160
Li, S. H., Shin, D. H., Chun, Y.-S., Lee, M. K., Kim, M.-S., & Park, J.-W. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0074 · Cited by 160
Reactive Oxygen Species, NADPH Oxidases, and Hypertension
Datla, S. R., & Griendling, K. K. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.142422 · Cited by 152
Turning Back the Clock: Adopting a Healthy Lifestyle in Middle Age
King, D. E., Mainous, A. G., & Geesey, M. E. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.09.020 · Cited by 151
Zielonka, J., Hardy, M., & Kalyanaraman, B. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.10.031 · Cited by 151
Phosphodiesterase inhibitors for the treatment of pulmonary hypertension
Wilkins, M. R., Wharton, J., Grimminger, F., & Ghofrani, H. A. (2008) · European Respiratory Journal · doi:10.1183/09031936.00124007 · Cited by 151
Trotter, E. W., & Grant, C. M. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03216.x · Cited by 146
NADPH Oxidase Inhibitors: New Antihypertensive Agents?
Williams, H. C., & Griendling, K. K. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318063e820 · Cited by 146
Zhang, Y., Griendling, K. K., Dikalova, A., Owens, G. K., & Taylor, W. R. (2005) · Hypertension · doi:10.1161/01.hyp.0000182660.74266.6d · Cited by 141
Rizvi, A. A. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181a4158c · Cited by 138
NADPH oxidases and cardiac remodelling
Nabeebaccus, A., Zhang, M., & Shah, A. M. (2011) · Heart Failure Reviews · doi:10.1007/s10741-010-9186-2 · Cited by 138
Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells
Stielow, C., Catar, R. A., Müller, G. M., Wingler, K., Scheurer, P., Schmidt, H. H. H. W., & Morawietz, H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.114 · Cited by 127
Self-citationGudmundsson, G. H., Magnússon, K. P., Chowdhary, B. P., Johansson, M., Andersson, L., & Boman, H. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.7085 · Cited by 125
Jackman, K. A., Miller, A. A., Silva, T. M. D., Crack, P. J., Drummond, G. R., & Sobey, C. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00073.x · Cited by 120
Guzik, T. J., Sadowski, J., Kapelak, B., Jopek, A., Rudziński, P., Pillai, R. G., Korbut, R., & Channon, K. M. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000139011.94634.9d · Cited by 120
Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice
Bhandarkar, S. S., Jaconi, M. E., Fried, L. E., Bonner, M. Y., Lefkove, B., Govindarajan, B., Perry, B. N., Parhar, R., MacKelfresh, J. B., Sohn, A. M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci33877 · Cited by 117
S17834, a New Inhibitor of Cell Adhesion and Atherosclerosis That Targets NADPH Oxidase
Cayatte, A. J., Rupin, A., Oliver-Krasinski, J. M., Maitland, K. A., Sansilvestri, P., Boussard, M.-F., Wierzbicki, M., Verbeuren, T. J., & Cohen, R. A. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1001.096723 · Cited by 116
Hydrogen peroxide as an endothelium-derived hyperpolarizing factor
Shimokawa, H. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0790-8 · Cited by 115
Zhang, X., Min, X., Li, C., Benjamin, I. J., Qian, B., Zhang, X., Ding, Z., Gao, X., Yao, Y., Ma, Y., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.147066 · Cited by 114
Tetrahydrobiopterin Inhibits Monomerization and Is Consumed during Catalysis in Neuronal NO Synthase
Reif, A., Fröhlich, L. G., Kotsonis, P., Frey, A., Bömmel, H. M., Schmidt, H. H. H. W., Wink, D. A., & Pfleiderer, W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24921 · Cited by 113
Self-citationDhamrait, S. S. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.01.007 · Cited by 110
Meurer, S., Pioch, S., Pabst, T., Opitz, N., Schmidt, P. M., Beckhaus, T., Wagner, K., Matt, S., Gegenbauer, K., Geschka, S., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.198234 · Cited by 107
Self-citationParadoxical Activation of Endothelial Nitric Oxide Synthase by NADPH Oxidase
Zhang, Q., Malik, P., Pandey, D., Gupta, S. A., Jagnandan, D., de Chantemèle, E. J. B., Bánfi, B., Marrero, M. B., Rudic, R. D., Stepp, D. W., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.168278 · Cited by 106
Melichar, V. O., Behr‐Roussel, D., Zabel, U., UTTENTHAL, L. O., Rodrigo, J., Rupin, A., Verbeuren, T. J., Kumar, A. H. S., & Schmidt, H. H. H. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405509101 · Cited by 102
Self-citationSingh, R. B., Ghosh, S., Niaz, M. A., Singh, R., Beegum, R., Chibo, H., Shoumin, Z., & Postiglione, A. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80348-8 · Cited by 101
Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition
Chen, W., Pendyala, S., Natarajan, V., Garcia, J. G. N., & Jacobson, J. R. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00428.2007 · Cited by 100
Reduced NAD(P)H Oxidase in Low Renin Hypertension
Zhou, M.-S., Schulman, I. H., Pagano, P. J., Jaimes, E. A., & Raij, L. R. (2005) · Hypertension · doi:10.1161/01.hyp.0000197182.65554.c7 · Cited by 99
Lange, S., Heger, J., Euler, G., Wartenberg, M., Piper, H. M., & Sauer, H. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn258 · Cited by 97
NADPH oxidase 5 (NOX5) interacts with and is regulated by calmodulin
Tirone, F., & Cox, J. A. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.02.047 · Cited by 96
Nishiyama, A., Yoshizumi, M., Hitomi, H., Kagami, S., Kondo, S., Miyatake, A., Fukunaga, M., Tamaki, T., Kiyomoto, H., Kohno, M., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000108523.02100.e0 · Cited by 95
Vendrov, A. E., Madamanchi, N. R., Niu, X.-L., Molnar, K., Runge, M., Szyndralewiez, C., Page, P., & Runge, M. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.143917 · Cited by 93
NADPH oxidase Nox1 contributes to ischemic injury in experimental stroke in mice
Kahles, T., Kohnen, A., Heumueller, S., Rappert, A., Bechmann, I., Liebner, S., Wittko, I. M., Neumann-Haefelin, T., Steinmetz, H., Schroeder, K., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.023 · Cited by 91
Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition
Schluter, T., Steinbach, A. C., Steffen, A., Rettig, R., & Grisk, O. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn185 · Cited by 90
The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stress
Riganti, C., Costamagna, C., Bosìa, A., & Ghigo, D. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.07.011 · Cited by 88
cGMP: Generators, Effectors and Therapeutic Implications
Schmidt, H. H. H. W., Hofmann, F. B., & Stasch, J. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-68964-5 · Cited by 83
Self-citationAngiotensin II and NADPH Oxidase Increase ADMA in Vascular Smooth Muscle Cells
Luo, Z., Teerlink, T., Griendling, K. K., Aslam, S., Welch, W. J., & Wilcox, C. S. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.152959 · Cited by 83
Phenothiazine: The Parent Molecule
Mitchell, S. C. (2006) · Current Drug Targets · doi:10.2174/138945006778226552 · Cited by 82
Settergren, M., Böhm, F., Malmström, R. E., Channon, K. M., & Pernow, J. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.08.034 · Cited by 80
Vanhoutte, P. M. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.190215 · Cited by 76
gp91phox Contributes to NADPH oxidase activity in aortic fibroblasts but not smooth muscle cells
Chamseddine, A. H., & Miller, F. J. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00459.2003 · Cited by 75
Hydrogen peroxide is an endothelium‐dependent contracting factor in rat renal artery
Gao, Y., & Lee, R. M. K. W. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706423 · Cited by 74
McCann, S., Dusting, G. J., & Roulston, C. L. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21700 · Cited by 72
Superoxide contributes to vascular dysfunction in mice that express human renin and angiotensinogen
Didion, S. P., Ryan, M. J., Baumbach, G. L., Sigmund, C. D., & Faraci, F. M. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00079.2002 · Cited by 68
Biomarkers of Inflammation and Oxidative Stress in Atherosclerosis
Uno, K., & Nicholls, S. J. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.57 · Cited by 65
Opitz, N., Drummond, G. R., Selemidis, S., Meurer, S., & Schmidt, H. H. H. W. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.11.003 · Cited by 64
Self-citationHoffmann, L., Schmidt, P., Keim, Y., Schaefer, S., Schmidt, H. H. H. W., & Stasch, J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00263.x · Cited by 64
Self-citationPro-oxidant activity of apocynin radical
Castor, L. R. G., Locatelli, K. A., & Ximenes, V. F. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.03.010 · Cited by 63
Kotsonis, P., Fröhlich, L. G., SHUTENKO, Z., Horejsi, R., Pfleiderer, W., & Schmidt, H. H. H. W. (2000) · Biochemical Journal · doi:10.1042/bj3460767 · Cited by 62
Self-citationDotan, Y., Pinchuk, I., Lichtenberg, D. A., & Leshno, M. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.178699 · Cited by 60
Zanfolin, M., Faro, R., de Araújo, E. G., Guaraldo, A. M. A., Antunes, E., & Nucci, G. D. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000210071.54828.9b · Cited by 56
Small-Molecule Inhibitors of NADPH Oxidase 4
Borbély, G., Szabadkai, I., Horváth, Z., Markó, P., Varga, Z. V., Breza, N., Baska, F., Vántus, T., Huszár, M., Geiszt, M., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1004368 · Cited by 53
Tsai, M.-H., & Jiang, M. J. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-67 · Cited by 51
Soluble guanylyl cyclase activation by HMR-1766 (ataciguat) in cells exposed to oxidative stress
Zhou, Z., Pyriochou, A., Kotanidou, A. N., Dalkas, G. A., van Eickels, M., Spyroulias, G. A., Roussos, C., & Papapetropoulos, A. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.51.2008 · Cited by 50
Tazzeo, T., Worek, F., & Janssen, L. J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00394.x · Cited by 42
Wang, P., Tang, F., Li, R., Zhang, H., Chen, S., Liu, P., & Huang, H. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.01.016 · Cited by 40
Imamura, F., Jacques, P. F., Herrington, D. M., Dallal, G. E., & Lichtenstein, A. H. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27576 · Cited by 40
Kirsch, M., Kemp‐Harper, B. K., Weißmann, N., Grimminger, F., & Schmidt, H. H. H. W. (2007) · The FASEB Journal · doi:10.1096/fj.06-7526com · Cited by 34
Self-citationPark, Y. M., Lim, B. H., Touyz, R. M., & Park, J. B. (2008) · Journal of Korean Medical Science · doi:10.3346/jkms.2008.23.6.1039 · Cited by 34
Fujii, A., Nakano, D., Katsuragi, M., Ohkita, M., Takaoka, M., Ohno, Y., & Matsumura, Y. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.09.039 · Cited by 32
Effects of the sGC Stimulator BAY 41-2272 Are Not Mediated by Phosphodiesterase 5 Inhibition
Bischoff, E., & Stasch, J. (2004) · Circulation · doi:10.1161/01.cir.0000142209.28862.12 · Cited by 32
Schluter, T., Zimmermann, U., Protzel, C., Miehe, B., Klebingat, K.-J., Rettig, R., & Grisk, O. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp346 · Cited by 27
Schmidt, H. H. H. W., Hofmann, F. B., & Stasch, J. (2009) · PubMed · Cited by 26
Self-citationKawano, H., & Yano, K. (2006) · Circulation Journal · doi:10.1253/circj.70.1116 · Cited by 20
Methods to Evaluate the Pharmacology of Oral Antiplatelet Drugs
Weber, A., Adamzik, M., Bachmann, H. S., Görlinger, K., Grandoch, M., Leineweber, K., Müller-Beißenhirtz, H., Wenzel, F., & Naber, C. K. (2008) · Herz · doi:10.1007/s00059-008-3132-2 · Cited by 18
Vitamin E supplementation: what's the harm in that?
Miller, E. R., & Güallar, E. (2009) · Clinical Trials · doi:10.1177/1740774509103248 · Cited by 10
Regulation of Adhesion Molecules: A New Target for the Treatment of Chronic Venous Insufficiency
Verbeuren, T. J., Bouskela, E., Cohen, R. A., & Vanhoutte, P. M. (2000) · Microcirculation · doi:10.1111/j.1549-8719.2000.tb00150.x · Cited by 8
Research works printed but not linked: 1
- 10.1042/0264-6021:3460767 · DOI
Cited by
Sorted by citations
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Drummond, G. R., Selemidis, S., Griendling, K. K., & Sobey, C. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3403 · Cited by 899
Functions of ROS in Macrophages and Antimicrobial Immunity
Herb, M., & Schramm, M. (2021) · Antioxidants · doi:10.3390/antiox10020313 · Cited by 633
Antioxidant effects of resveratrol in the cardiovascular system
Xia, N., Daiber, A., Förstermann, U., & Li, H. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13492 · Cited by 583
NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets
Zhang, Y., Murugesan, P., Huang, K., & Cai, H. “. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0260-8 · Cited by 551
Evolution of nadph oxidase inhibitors: Selectivity and mechanisms for target engagement
Altenhöfer, S., Radermacher, K. A., Kleikers, P. W. M., Wingler, K., & Schmidt, H. H. H. W. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5814 · Cited by 521
Self-citation
Metadata
- Authors
- Wingler, K., Hermans, J., Schiffers, P., Moens, A., Paul, M., & Schmidt, H.
- Affiliations
- Maastricht University (NL)
- Maastricht University Medical Centre (NL)
- ORCID
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2011-09-08
- Volume
- 164
- Issue
- 3
- Pages
- 866-883
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC3195911
- OpenAlex
- W1512037315
- Cited by
- 113
- References
- 176
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 7 · 2021: 8 · 2020: 9 · 2019: 6 · 2018: 8 · 2017: 5 · 2016: 7 · 2015: 8 · 2014: 12 · 2013: 15 · 2012: 15
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- ZonMw
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Servier
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- oxidative stress, NADPH oxidase, NOX1, NOX2, NOX4, NADPH oxidase 5, reactive oxygen species, endothelial dysfunction, cardiovascular disease, antioxidant supplementation, soluble guanylate cyclase, NADPH oxidase inhibitors
- MeSH terms
- Animals, Cardiovascular Agents, Cardiovascular Diseases, Humans, Oxidative Stress, NADPH Oxidases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review